Reading Your Urology CT or MRI Report: What the Radiologist Notes and How the Urologist Uses It

The notification arrives on a Tuesday evening, three days before the appointment. A PDF opens on the phone at the kitchen table: two dense pages, a list of numbered findings, and near the bottom a phrase that stops the scrolling thumb. “PI-RADS 4 lesion, left peripheral zone.” Underneath it, almost apologetically, “No lymphadenopathy.” Nobody in the house knows which of those sentences matters more.

That evening gap between report and conversation is where most of the worry lives. This guide is a urology MRI report explained the way a radiologist and a urologist would explain it to each other, translated into plain English: what each section is for, what the scores and shorthand actually claim, and, just as usefully, what they do not claim.

It also covers the CT side of the clinic, because kidney stones, blood in the urine and “incidental” cysts generate at least as many anxious evenings as prostate scans do. The aim is not to replace the appointment but to make it a two-way conversation.

Your urology MRI report explained: the five parts every report has

Radiology reports look different from one department to another, but almost all of them follow the same skeleton. Once you can see the skeleton, the two pages stop feeling like a wall of jargon.

The clinical indication comes first: the reason the scan was ordered, often just a few words such as “raised PSA” or “visible haematuria, query cause.” It tells you what question the radiologist (the doctor trained to interpret medical images) was trying to answer. A report is always an answer to a question, and findings outside that question are labelled accordingly.

The technique paragraph lists what was done: which sequences were run on the MRI, whether contrast was given, what phases were acquired on the CT. It matters because a scan done without contrast simply cannot comment on some things, and the report will say so.

A comparison line names any earlier imaging. “Unchanged from prior” is one of the most reassuring phrases in medicine, and it can only be written when an old scan was available.

The findings section is the long, descriptive part, usually organised by organ: prostate, seminal vesicles, bladder, kidneys, lymph nodes, bones. It is written for the urologist, the surgeon who specialises in the urinary tract and male reproductive organs, so it uses measurements and shorthand rather than reassurance.

The impression is the summary. Findings are ranked by importance, and this is the part the urologist reads first. If a phrase in the findings frightens you but does not appear in the impression, the radiologist has usually judged it minor. If something appears in both, that is the item your appointment will centre on.

How prostate MRI actually works: three pictures of one gland

A prostate MRI is usually described as multiparametric, which simply means the scanner takes several different kinds of picture of the same gland and the radiologist reads them together. Each picture answers a different question.

T2-weighted images show anatomy. Water-rich tissue appears bright, so the normal peripheral zone (the outer part of the prostate, where most cancers begin) looks pale, while the transition zone (the inner part that enlarges with age) looks like a mottled patchwork. A suspicious area in the peripheral zone typically shows up as a darker, ill-defined patch against that pale background.

Diffusion-weighted images measure how freely water molecules move. Tightly packed tumour cells restrict that movement, so a suspicious focus glows bright on the diffusion image and dark on the matching ADC map (a calculated image of the same data, read in the opposite direction). For the peripheral zone this is the sequence the score leans on most, according to the PI-RADS version 2.1 guidance published in European Urology.

Dynamic contrast-enhanced images track a gadolinium-based contrast agent as it washes through the gland over a few minutes. Tumours often take it up early and briskly. Some centres omit this sequence in a so-called biparametric protocol, and the report’s technique line will tell you which was done.

None of these pictures shows cancer directly. They show tissue behaving in ways that cancer tends to behave. Prostatitis, recent biopsy bleeding and benign enlargement can imitate those behaviours, which is why the report speaks in probabilities rather than verdicts.

What does a prostate MRI score of 1 to 5 mean?

PI-RADS stands for Prostate Imaging Reporting and Data System, a standardised scale that answers one narrow question: how likely is it that this area contains clinically significant cancer, meaning cancer that would matter if found? It is not a grade of aggressiveness and not a stage. Each lesion receives its own score, and the report’s overall score is that of the most suspicious one, often called the index lesion.

Score	What the radiologist is saying	How the urologist usually reads it
1	Very low: clinically significant cancer highly unlikely	Often discussed alongside PSA trend and other risk factors before deciding on biopsy
2	Low: clinically significant cancer unlikely	As above; a normal-appearing scan carries weight but is not a guarantee
3	Intermediate or equivocal: the images cannot say either way	The hardest call; other information decides the next step
4	High: clinically significant cancer likely	Biopsy is commonly offered to confirm or refute
5	Very high: clinically significant cancer highly likely	Biopsy is commonly offered; staging details in the report become important

A few mechanics help explain why two lesions that look similar to a layperson land on different numbers. Under version 2.1, a peripheral zone lesion that would otherwise score 3 can be lifted to 4 if the contrast sequence shows early focal enhancement. A lesion that would score 4 becomes a 5 if it measures 1.5 cm or more, or if it clearly breaches the gland’s edge.

Two readers can also disagree, particularly around the 3 boundary; the PI-RADS authors themselves list reader variability as a known limitation. That is one reason many urology teams have prostate scans double-read or discussed in a meeting before decisions are made.

Urology MRI report explained beyond the score: volume, density and staging lines

The PI-RADS number gets the attention, but urologists routinely spend more time on the sentences around it.

Prostate volume is usually measured in millilitres from three diameters. On its own a large gland is not sinister; the transition zone enlarges with age in most men. Volume matters because it lets the urologist calculate PSA density: the blood PSA value divided by the gland volume. A modest PSA from a very large gland is less concerning than the same PSA from a small one, and PSA density is one of the factors that helps decide what to do with an equivocal scan.

Location is recorded on a sector map, the left peripheral zone at mid-gland for instance, so that a biopsy needle can be steered to the same spot. Peripheral zone lesions are scored mainly on the diffusion sequence; transition zone lesions mainly on T2, because the background there is already busy with benign nodules.

The staging lines describe the relationship between any lesion and the gland’s borders. “Capsule intact” or “no extraprostatic extension” means the radiologist saw no sign of growth beyond the gland. “Broad capsular contact” or “bulging” is a softer warning that the edge may be involved. The seminal vesicles (two small glands behind the prostate) and the neurovascular bundles (nerves running alongside it that matter for erections and continence) are each mentioned because they influence surgical planning.

Finally, the report comments on pelvic lymph nodes and bones, usually by size or signal. “No suspicious lymphadenopathy” and “no focal bone lesion” are the quiet sentences that often carry the most reassurance.

Can an MRI tell if a prostate lesion is cancerous?

No. An MRI can estimate how likely a lesion is to be clinically significant cancer, and it can do that far better than the older approach of biopsying blindly, but only tissue under a microscope confirms a diagnosis.

The evidence behind that statement is unusually clear. The PROMIS study, published in The Lancet, gave men a multiparametric MRI, a standard ultrasound-guided biopsy and a detailed template biopsy of the whole gland as the reference standard. MRI detected 93% of clinically significant cancers; standard biopsy on its own detected 48%. Among men whose MRI looked non-suspicious, the negative predictive value was 89%, meaning roughly nine in ten truly had no significant cancer.

The PRECISION trial in the New England Journal of Medicine then tested MRI as the gatekeeper. Men randomised to MRI first, with biopsy only of suspicious areas, had clinically significant cancer found in 38% of cases, compared with 26% in the standard biopsy group; 28% of the MRI group avoided biopsy altogether, and fewer clinically insignificant cancers were picked up.

Read those figures both ways. A non-suspicious scan is genuinely reassuring, and it is why many national pathways, including the NHS pathway, now place MRI before biopsy. But 89% is not 100%. Some significant cancers are invisible on MRI, particularly small ones or those with a diffuse growth pattern, and some bright, worrying-looking lesions turn out to be inflammation or a benign nodule at biopsy.

So when a report says “lesion suspicious for clinically significant carcinoma,” the honest translation is: the odds have shifted enough that a biopsy is worth discussing. The decision about whether to have one belongs to you and your urologist, weighed against your PSA, examination, age, family history and preferences.

What is a PI-RADS 3 lesion, and why is it the hard case?

A PI-RADS 3 lesion is the radiologist saying, with professional candour, “I cannot tell.” The area is not clean enough to call low risk and not convincing enough to call high risk. Under version 2.1 the category exists precisely so that uncertainty is recorded rather than forced into a false yes or no.

Several things push a lesion into this middle ground. In the transition zone, benign nodules can look like circumscribed, well-organised marbles (typically scored 2) or become smudgy and lose their edges, at which point the scoring nudges toward 3. In the peripheral zone, a mild, patchy signal change that is not focal enough to score 4 lands here too. Prostatitis and post-biopsy blood are frequent impostors.

Because the images cannot settle the question, the urologist reaches for everything else on the desk:

• PSA density, calculated from the volume in the same report.
• The PSA trend over time rather than a single value.
• Findings on rectal examination.
• Age, family history and, where available, genetic risk information.
• Whether a previous biopsy exists and what it showed.
• The size of the lesion and whether it has changed on a prior scan.

Depending on that picture, three broad routes are usually laid out: a targeted biopsy of the lesion (often combined with systematic samples of the rest of the gland), a repeat MRI after an interval to see whether anything changes, or continued PSA monitoring without immediate biopsy. The PI-RADS authors are explicit that the equivocal category is where reader disagreement is greatest, so it is entirely reasonable to ask whether a second radiologist has looked at your images. Whichever route is chosen, it should be a shared decision, not a number on a page making it for you.

Who is usually offered a urology MRI or CT, and who is asked to wait

Imaging in urology is chosen to answer a specific question, and the same scan can be exactly right for one person and unhelpful for another.

Prostate MRI is most often ordered when a PSA blood test or a rectal examination raises concern, before any biopsy, following the pathway described by the NHS. It is also used to monitor men on active surveillance for a low-risk cancer that has already been diagnosed, and, less commonly, to stage a known cancer before treatment planning.

CT tends to be chosen when the question involves the kidneys, ureters (the tubes carrying urine from kidney to bladder) or bladder. A low-dose non-contrast CT is the usual test for suspected kidney stones because stones show up brightly without any injection. A CT urogram, with contrast and delayed images, is commonly used to investigate visible blood in the urine or a suspected kidney mass.

Some people are asked to wait, or offered a different test:

• After a recent prostate biopsy, bleeding inside the gland can mimic or mask a lesion, so many centres defer MRI for a period; ask your team what interval they use.
• During an active urinary infection or prostatitis, inflammation can distort the images.
• People with significantly reduced kidney function may be offered non-contrast protocols, because both iodinated CT contrast and gadolinium carry considerations in that setting.
• Certain implanted devices or metal fragments need safety clearance before MRI; many modern devices are compatible, but the check is not optional.
• CT involves ionising radiation, so pregnancy prompts a discussion of ultrasound or MRI alternatives.

Claustrophobia is a reason to talk, not a reason to avoid the scan; positioning, music, an open-bore scanner or a mild sedative arranged by the prescribing clinician are all routinely discussed.

Reading CT urogram results: which phase shows what

A CT urogram is a CT scan of the urinary tract taken in stages, before and after an injection of iodine-based contrast, so that the kidneys, ureters and bladder can each be examined when they are best displayed. The technique line of your report will list the phases, and each finding belongs to one of them.

The non-contrast phase comes first. Anything already dense, such as a stone or a calcified cyst wall, is easiest to see here before contrast makes everything bright. This is also where the radiologist records a baseline density for any mass, measured in Hounsfield units (a scale of how much X-ray a tissue absorbs).

The nephrographic phase, taken once contrast has soaked into the kidney tissue, is the mass-hunting phase. A simple cyst stays dark; a solid tumour brightens. That brightening after contrast is what the report calls enhancement, and it is the single most important word in a kidney mass report, because living tumour tissue has a blood supply and enhances, while fluid does not.

The excretory or delayed phase waits until contrast has been filtered into the urine, outlining the collecting system, ureters and bladder from the inside. A filling defect means something is displacing the bright urine, which could be a stone, a clot or a growth of the urothelium (the lining of the urinary tract). Urothelial thickening describes a lining that looks thicker than expected, sometimes from inflammation, sometimes from something that needs a camera test.

You may also meet perinephric stranding (hazy fat around the kidney, often from inflammation or recent obstruction), cortical scarring (old damage) and extrarenal pelvis, a normal variant where the kidney’s funnel sits partly outside the kidney and can be mistaken for swelling.

Hydronephrosis on CT scan: what a dilated collecting system really means

Hydronephrosis means the drainage system inside the kidney is stretched wider than normal by urine. It is a description, not a diagnosis, and the same word covers everything from a harmless variant to a kidney under real pressure.

Reports usually grade it as mild, moderate or severe, based on how much the renal pelvis and the calyces (the cup-shaped chambers that collect urine) have widened and whether the kidney tissue itself is thinning. Mild hydronephrosis is common and frequently transient. Severe hydronephrosis with a thinned cortex suggests the pressure has been there long enough to matter.

The urologist’s first question is always where the transition point is: the level at which a dilated ureter becomes a normal one. A stone lodged where the ureter enters the bladder, a narrowing (stricture) higher up, and an enlarged prostate blocking the bladder outlet all produce hydronephrosis, but each points to a different plan. The NIH’s kidney institute lists these obstructive causes alongside non-obstructive ones such as urine flowing backwards from the bladder (vesicoureteral reflux) and the normal, temporary dilatation seen in pregnancy.

Second question: one side or both? Bilateral hydronephrosis usually points to a problem at or below the bladder, unilateral to something along one ureter.

Third: is the kidney still working? On a contrast study, a delay in the affected kidney taking up and excreting contrast, compared with the other side, tells the urologist how urgent the situation is.

One combination changes the tempo entirely. Hydronephrosis together with fever, chills or signs of infection is treated as an emergency, because infected urine trapped behind a blockage can spread quickly. That scenario is covered again in the red-flag section, because it deserves saying twice.

Kidney stones, cysts and masses: size, density and the Bosniak line

Three kinds of kidney finding account for most of the questions patients bring to clinic, and each has its own vocabulary.

Stones are described by size in millimetres, by location (within the kidney, in the upper, mid or lower ureter, or at the junction with the bladder) and often by density in Hounsfield units. Size and position together shape the conversation: smaller stones lower in the ureter are more likely to pass on their own, while larger stones or those causing significant obstruction are more likely to prompt a procedure. Density gives a hint about composition, which can influence how the urologist plans management, though the decision rests with the team and your symptoms. The report may also note skin-to-stone distance, which is relevant if shock-wave treatment is being considered.

Cysts, fluid-filled sacs, are extremely common with age and most are harmless. Radiologists classify them with the Bosniak system, a scale from I to IV that describes how simple or complex a cyst looks. Category I is a thin-walled sac of pure fluid and needs nothing. Category II has a few thin septations or fine calcification and is also considered benign. Category IIF (F for follow-up) is a little more complex and is watched with repeat imaging. Categories III and IV show thickened walls, nodules or enhancing tissue and are usually discussed for possible treatment. Most reports state the category outright; if yours does not, ask.

Solid masses hinge on that word enhancement. An enhancing solid mass is treated as a possible tumour until proven otherwise, though not every enhancing mass is malignant. A mass containing visible fat is often a benign angiomyolipoma, and the report will usually say so.

An adrenal nodule may appear as an aside, because the adrenal glands sit on top of the kidneys. Most are incidental and benign, but they are generally passed to the appropriate specialist for a brief assessment.

"Nonspecific," "cannot exclude," "incidental": decoding the hedge phrases

Radiology reports are written by careful people describing imperfect pictures, and the language reflects that. A few phrases cause outsized anxiety and deserve a plain translation.

“Nonspecific” means the appearance could be produced by several different causes and the image alone cannot choose between them. It is not code for something bad.

“Cannot exclude” or “cannot be entirely excluded” is the radiologist declining to promise a negative that the scan cannot prove. “Small focus of restricted diffusion, cannot exclude low-volume tumour” tells the urologist to weigh it, not to panic about it.

“Correlate clinically” hands the finding back to the doctor who can examine you. The radiologist sees a picture; the urologist has your history, blood tests and symptoms, and only that combination produces a decision.

“Incidental” means found by accident while looking for something else. Cross-sectional scans routinely turn up incidental liver cysts, gallstones, spinal wear and small lung nodules. Most are harmless. Some generate a line such as “recommend follow-up imaging,” which is a suggestion to the referring doctor rather than an instruction to you.

“Limited study” or “degraded by motion artifact” is the radiologist flagging that image quality was not ideal, perhaps because of hip implants, bowel gas or movement. A limited study can still be useful, but a repeat may be discussed.

“Unchanged from prior” and “stable” are, in this vocabulary, the warm words. A finding that has looked the same across years is behaving benignly whatever it is.

Notice what none of these phrases does: they do not diagnose, and they do not decide. The report’s job is to describe accurately. Meaning is added in the consulting room.

What the days and weeks after the report usually look like

The report is a beginning, not an end, and the sequence that follows is fairly predictable even when the details differ.

First, the referring urologist reads it, usually alongside the images rather than the text alone. Prostate scans with suspicious lesions, complex cysts and kidney masses are often taken to a multidisciplinary team meeting, where radiologists, urologists, pathologists and oncologists review cases together. If you are told your case is “going to MDT,” that is routine quality control, not a sign that something unusual has been found.

For a prostate MRI that shows a PI-RADS 4 or 5 lesion, the next step commonly discussed is a targeted biopsy. The MRI images are fused with live ultrasound so that needles can be guided to the lesion, usually with additional systematic samples. Biopsies are performed either through the skin between the scrotum and anus (transperineal) or through the rectal wall (transrectal); your team will explain which they use and why. Tissue then goes to a pathologist, and the wait for that result is often the longest part of the process. Ask what the typical turnaround is where you are treated.

For a non-suspicious prostate MRI, the conversation usually turns to PSA monitoring and whether any other risk factors still justify a biopsy.

For men on active surveillance, a repeat MRI is one of several tools used to check that a known low-risk cancer is behaving; a stable scan is reassuring, and a new or growing lesion prompts discussion.

On the CT side, a stone report leads to a plan for passage, pain control or a procedure; visible blood in the urine with a clear CT still usually leads to cystoscopy, a camera examination of the bladder; a Bosniak IIF cyst earns a date for repeat imaging; an enhancing mass earns a fuller staging discussion.

In every branch, the report informs the decision and the team, with you, makes it.

What people often get wrong about prostate MRI and urology CT reports

Some misunderstandings surface so often in clinic that they are worth correcting directly.

“PI-RADS 5 means I definitely have cancer.” It means the probability is high enough that biopsy is strongly worth discussing. Inflammation, benign nodules and previous bleeding can all mimic a high-scoring lesion, which is exactly why tissue is still needed.

“PI-RADS 1 or 2 means I never need to think about my prostate again.” PROMIS found that a non-suspicious MRI carried a negative predictive value of 89% for significant cancer. That is a strong result, and it is not a guarantee, particularly if PSA keeps climbing. Follow-up is usually still advised.

“Ejaculation before the scan ruins it.” The evidence here is thin and inconsistent. Ejaculation may temporarily reduce the volume of the seminal vesicles, and some centres ask for a short period of abstinence beforehand; the PI-RADS guidance notes the practice without mandating it. A scan performed without abstinence is not invalid. Follow whatever instructions your imaging centre gives, and mention it if you did not.

“A big prostate means cancer.” Benign enlargement is what most prostates do with age. Volume is reported so that PSA density can be calculated, not as a warning in itself.

“An unremarkable CT means my symptoms are imaginary.” CT answers structural questions. Bladder pain, urgency and some causes of blood in the urine are not structural and may need cystoscopy or urodynamic testing instead.

“The computer reads the scan now.” Artificial intelligence tools are being evaluated as aids for detecting and outlining lesions. In routine practice a radiologist remains responsible for the report, and the score you see was assigned by a person.

“If it were serious, they would have phoned.” Sometimes true, often not; reporting and communication follow different timelines. Do not read reassurance into silence. Read it in the appointment.

Questions to ask your care team about your urology imaging report

A good appointment is one where you leave understanding not just what was found but what it changes. Bring the report, bring a second pair of ears if you can, and consider asking some of the following.

• Which finding in the impression matters most, and which can I set aside?
• What was the overall PI-RADS score, which zone is the lesion in, and how large is it?
• What is my PSA density, and how does it alter your reading of the scan?
• Does the report describe the capsule, seminal vesicles, lymph nodes and bones as clear?
• Has a second radiologist reviewed the images, or will my case go to a multidisciplinary meeting?
• If a biopsy is suggested, how would it be done, what are the common risks, and what would happen if I chose to wait instead?
• If no biopsy is suggested, what monitoring is planned and what would change that plan?
• For a CT: where exactly is the stone or blockage, is the kidney draining, and is my kidney function affected?
• What Bosniak category is my cyst, and what follow-up does that carry?
• Are any incidental findings being passed to another specialist, and do I need to do anything about them?
• Was the study technically complete, or is a repeat scan being considered?
• Who do I contact if I develop new symptoms before the next appointment?

You are also entitled to ask for a copy of the images themselves, not just the report, and to request that the reasoning behind any recommendation be explained in plain language. None of this slows your care. Clinicians generally find that informed patients make clearer decisions, and clearer decisions are safer ones.

When to call your doctor

Most imaging findings unfold over weeks, but a few situations should not wait for the scheduled appointment. Seek urgent care the same day if any of the following occur.

• Fever, chills or shaking alongside flank pain, or within days of a prostate biopsy or urinary procedure. Infection behind a blockage or after instrumentation can escalate quickly.
• Inability to pass urine at all, or passing only small dribbles with a painful, distended lower abdomen.
• Severe, unrelenting flank or abdominal pain, especially with vomiting, or pain that no longer responds to the measures your team advised.
• Heavy visible blood in the urine with clots, or bleeding after a biopsy that is not settling.
• After contrast: swelling of the lips or face, difficulty breathing, widespread rash or feeling faint. These are signs of an allergic reaction and need emergency help.
• New back pain with leg weakness, numbness or loss of bladder or bowel control, particularly if the report mentioned any bone or spinal finding.
• A single kidney, transplant kidney or known kidney disease combined with any of the above.

Call your urology team or GP promptly, though not necessarily as an emergency, if you have not been contacted within the timeframe you were told to expect after a scan, if you develop new urinary symptoms while waiting, or if you have read something in the report that you do not understand and it is affecting your sleep. That last one is a legitimate reason to pick up the phone; reassurance is part of care.

Every decision described in this article, from whether to biopsy to how to manage a stone, sits with the clinicians who know your full history. The report tells them what the pictures show. You tell them what matters to you.

Frequently asked questions

How do I interpret my prostate MRI results if no PI-RADS score is listed?

Look first at the impression for words such as suspicious, equivocal or no focal lesion, which usually map onto the PI-RADS categories even when the number is omitted. Some older or non-standard reports describe lesions narratively. Ask your urologist to translate the description into a category, and whether the study was multiparametric or biparametric, because that affects how the findings should be read.

What is the prostate MRI score meaning when my report says PI-RADS 2?

PI-RADS 2 means clinically significant cancer is considered unlikely in the area described; benign changes such as well-defined transition zone nodules commonly receive this score. It does not rule cancer out entirely, since some cancers are not visible on MRI. Your urologist will weigh it against your PSA trend, PSA density and examination before deciding whether monitoring alone is appropriate.

Does ejaculating affect a prostate MRI?

Probably only slightly, and the evidence is inconsistent. Ejaculation may temporarily reduce the size of the seminal vesicles, which some radiologists prefer to see fully distended, so certain centres request a short period of abstinence beforehand. The PI-RADS guidance does not make this mandatory, and a scan performed without abstinence remains interpretable. Follow your imaging centre’s instructions and mention it if you did not.

Can an MRI tell if a prostate lesion is cancerous?

No. MRI estimates probability; only a biopsy examined by a pathologist confirms cancer. That said, the estimate is good: in the PROMIS study MRI detected 93% of clinically significant cancers, far more than standard biopsy alone. High-scoring lesions are still sometimes inflammation or benign nodules, and low-scoring scans occasionally hide small cancers, which is why imaging and tissue sampling are used together.

What is the difference between CT urogram results and a regular abdominal CT?

A CT urogram is a purpose-built study of the urinary tract with several phases, including a delayed phase in which contrast has reached the urine and outlines the ureters and bladder from inside. A standard abdominal CT usually has one phase and may not show the lining of the ureters or subtle bladder abnormalities. Your report’s technique line states which was performed.

My CT says mild hydronephrosis on one side. Is that an emergency?

Usually not on its own. Mild hydronephrosis is common, sometimes transient and sometimes a normal variant, and your urologist will look for the cause and whether the kidney is draining. It becomes urgent if you also have fever, chills, severe pain, vomiting or difficulty passing urine, because an infected or completely blocked kidney needs prompt treatment. Report those symptoms the same day.

Why does my report say "correlate clinically"?

It is the radiologist handing a finding back to the doctor who can examine you. The scan shows an appearance; your urologist has your symptoms, blood results and history, and only that combination gives the finding meaning. The phrase is standard, appears on a large share of reports and is not a signal that something serious was seen.

What does extraprostatic extension mean on my MRI report?

Extraprostatic extension means the radiologist sees signs that a lesion may have grown through the prostate’s outer edge into surrounding tissue. Reports may describe it as absent, suspected or definite, and mention capsular contact or bulging as softer signs. It influences how a cancer would be staged and treated if confirmed, but it remains an imaging impression until biopsy and other tests complete the picture.

Do I still need a biopsy if my prostate MRI is normal?

Not always. Many pathways, including the NHS pathway, allow men with a non-suspicious MRI to avoid immediate biopsy, and PRECISION found 28% of men in an MRI-first pathway did not need one. Your urologist may still advise biopsy if PSA density is high, PSA is rising steadily, examination is abnormal or family history is strong. Monitoring is the usual alternative.

Should I read my urology report before my urologist explains it?

It is your record and you are entitled to it, but read it knowing it was written for a specialist and lists everything seen, including trivia. Focus on the impression, note the phrases you do not understand, and bring them to the appointment. If a line is causing real distress before your visit, phone the clinic; asking for clarification early is reasonable.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.